Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
.
Main Authors: | P. F. Mulders, K. Miller, N. S. Tchekmedyian |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-02-01
|
Series: | Onkourologiâ |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1046 |
Similar Items
-
ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
by: S Yu Vorotnikova, et al.
Published: (2016-12-01) -
Short-Term Zoledronic Acid Reduces Trabecular Bone Remodeling In Aged Dogs
by: Helm, Nathan B.
Published: (2010) -
Nephrogenic Adenoma of the Urinary Bladder after Kidney Transplantation: Long-Term Follow-Up
by: Iftikhar Khan, et al.
Published: (2020-01-01) -
Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid
by: Jing Yi Wang, et al.
Published: (2019-01-01) -
Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
by: El Saghir Nagi S, et al.
Published: (2005-12-01)